Stock listing
Tradegate:BT3 Lineage Cell Therapeutics, Inc. Aktie
German listing (Tradegate) of Lineage Cell Therapeutics, Inc. · home listing NYSE American:LCTX
Follow Lineage Cell Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:LCTX
$0.953 USD -0.025 (-2.6%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:LCTX
- Day range
- $0.940 – $0.996 USDOct 19, 2026
- Volume
- 948,614 sharesOct 19, 2026
- Market value
- $240.6M USDAt the close on Oct 19, 2026 · price × 252.5M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:LCTX · Home | $0.953 USD | -0.025 (-2.6%) | 948,614 | $0.981 | $0.996 | $0.940 | $0.978 | Close on Oct 19, 2026 |
| TASE:LCTX | 300.90 ILA (agorot) | +14.70 (+5.1%) | 11,763 | 291.00 | 305.10 | 291.00 | 286.20 | Close on Oct 19, 2026 |
| Frankfurt:BT3 | €0.838 EUR | -0.019 (-2.2%) | — | €0.838 | €0.838 | €0.838 | €0.857 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · AMEX:LCTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.953 | -0.025 | -2.6% | $0.981 | $0.996 | $0.940 | 948,614 | |
| $0.978 | -0.012 | -1.2% | $0.980 | $1.000 | $0.960 | 1,308,652 | |
| $0.990 | +0.073 | +7.9% | $0.921 | $0.998 | $0.918 | 1,414,961 | |
| $0.918 | +0.009 | +1.0% | $0.914 | $0.932 | $0.890 | 2,182,539 | |
| $0.908 | -0.042 | -4.4% | $0.950 | $0.970 | $0.895 | 1,784,668 | |
| $0.950 | -0.040 | -4.0% | $1.000 | $1.000 | $0.940 | 1,687,000 | |
| $0.990 | -0.040 | -3.9% | $1.020 | $1.030 | $0.980 | 1,158,500 | |
| $1.030 | +0.080 | +8.4% | $0.950 | $1.050 | $0.930 | 2,009,800 | |
| $0.950 | +0.012 | +1.3% | $0.940 | $0.970 | $0.920 | 1,476,400 | |
| $0.938 | +0.010 | +1.1% | $0.941 | $0.965 | $0.925 | 967,620 | |
| $0.927 | -0.003 | -0.3% | $0.930 | $0.960 | $0.912 | 1,386,588 | |
| $0.930 | +0.030 | +3.3% | $0.920 | $0.960 | $0.890 | 1,249,300 | |
| $0.900 | -0.060 | -6.2% | $0.960 | $0.970 | $0.880 | 1,651,900 | |
| $0.960 | +0.010 | +1.1% | $0.950 | $0.990 | $0.940 | 1,267,800 | |
| $0.950 | -0.020 | -2.1% | $0.980 | $0.990 | $0.920 | 2,592,100 | |
| $0.970 | -0.060 | -5.8% | $1.020 | $1.040 | $0.960 | 1,574,200 | |
| $1.030 | +0.080 | +8.4% | $0.950 | $1.040 | $0.940 | 2,481,300 | |
| $0.950 | -0.010 | -1.0% | $0.950 | $0.970 | $0.910 | 2,439,900 | |
| $0.960 | -0.080 | -7.7% | $1.020 | $1.040 | $0.960 | 2,630,200 | |
| $1.040 | +0.030 | +3.0% | $1.020 | $1.050 | $1.000 | 846,800 | |
| $1.010 | -0.020 | -1.9% | $1.030 | $1.050 | $1.010 | 720,700 | |
| $1.030 | 0.000 | 0.0% | $1.020 | $1.060 | $1.000 | 3,209,200 | |
| $1.030 | -0.040 | -3.7% | $1.100 | $1.100 | $1.030 | 894,400 | |
| $1.070 | +0.010 | +0.9% | $1.060 | $1.120 | $1.030 | 1,639,500 | |
| $1.060 | -0.010 | -0.9% | $1.060 | $1.070 | $1.020 | 1,399,500 | |
| $1.070 | +0.060 | +5.9% | $1.010 | $1.080 | $1.010 | 1,840,100 | |
| $1.010 | -0.010 | -1.0% | $1.020 | $1.030 | $1.000 | 910,400 | |
| $1.020 | -0.010 | -1.0% | $1.020 | $1.030 | $1.000 | 1,197,700 | |
| $1.030 | -0.060 | -5.5% | $1.110 | $1.120 | $1.030 | 1,361,100 | |
| $1.090 | +0.010 | +0.9% | $1.100 | $1.160 | $1.090 | 1,312,122 | |
| $1.080 | -0.020 | -1.8% | $1.090 | $1.110 | $1.080 | 535,700 | |
| $1.100 | -0.010 | -0.9% | $1.110 | $1.120 | $1.090 | 916,500 | |
| $1.110 | +0.030 | +2.8% | $1.080 | $1.140 | $1.080 | 675,900 | |
| $1.080 | -0.020 | -1.8% | $1.100 | $1.120 | $1.080 | 902,700 | |
| $1.100 | -0.010 | -0.9% | $1.110 | $1.130 | $1.100 | 580,400 | |
| $1.110 | -0.050 | -4.3% | $1.160 | $1.180 | $1.110 | 587,300 | |
| $1.160 | +0.040 | +3.6% | $1.110 | $1.190 | $1.100 | 970,100 | |
| $1.120 | -0.010 | -0.9% | $1.160 | $1.160 | $1.100 | 800,200 | |
| $1.130 | +0.040 | +3.7% | $1.080 | $1.130 | $1.080 | 1,032,109 | |
| $1.090 | +0.010 | +0.9% | $1.080 | $1.110 | $1.060 | 607,680 | |
| $1.080 | 0.000 | 0.0% | $1.090 | $1.110 | $1.070 | 716,400 | |
| $1.080 | -0.020 | -1.8% | $1.090 | $1.100 | $1.040 | 1,474,300 | |
| $1.100 | +0.040 | +3.8% | $1.090 | $1.130 | $1.080 | 951,500 | |
| $1.060 | 0.000 | 0.0% | $1.060 | $1.080 | $1.050 | 1,112,400 | |
| $1.060 | -0.010 | -0.9% | $1.070 | $1.110 | $1.060 | 795,400 | |
| $1.070 | +0.010 | +0.9% | $1.060 | $1.090 | $1.050 | 1,129,400 | |
| $1.060 | -0.040 | -3.6% | $1.110 | $1.120 | $1.050 | 957,600 | |
| $1.100 | -0.020 | -1.8% | $1.120 | $1.130 | $1.090 | 698,000 | |
| $1.120 | -0.010 | -0.9% | $1.130 | $1.150 | $1.100 | 763,800 | |
| $1.130 | +0.030 | +2.7% | $1.100 | $1.150 | $1.090 | 752,300 | |
| $1.100 | -0.030 | -2.7% | $1.100 | $1.140 | $1.080 | 833,600 | |
| $1.130 | -0.010 | -0.9% | $1.160 | $1.180 | $1.120 | 711,600 | |
| $1.140 | +0.020 | +1.8% | $1.120 | $1.150 | $1.100 | 693,100 | |
| $1.120 | +0.010 | +0.9% | $1.130 | $1.150 | $1.110 | 860,800 | |
| $1.110 | +0.030 | +2.8% | $1.080 | $1.120 | $1.070 | 680,700 | |
| $1.080 | -0.030 | -2.7% | $1.110 | $1.130 | $1.070 | 948,700 | |
| $1.110 | +0.050 | +4.7% | $1.060 | $1.130 | $1.050 | 1,050,100 | |
| $1.060 | -0.010 | -0.9% | $1.070 | $1.080 | $1.020 | 1,398,800 | |
| $1.070 | +0.040 | +3.9% | $1.040 | $1.080 | $1.030 | 891,200 | |
| $1.030 | 0.000 | 0.0% | $1.030 | $1.080 | $1.000 | 1,706,000 | |
| $1.030 | -0.040 | -3.7% | $1.070 | $1.090 | $1.020 | 1,230,900 | |
| $1.070 | -0.040 | -3.6% | $1.110 | $1.120 | $1.070 | 1,025,100 | |
| $1.110 | -0.030 | -2.6% | $1.120 | $1.140 | $1.100 | 774,100 | |
| $1.140 | +0.040 | +3.6% | $1.110 | $1.140 | $1.100 | 762,900 | |
| $1.100 | -0.060 | -5.2% | $1.150 | $1.170 | $1.090 | 1,739,300 |
- Ticker
- Tradegate:BT3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Sep 8, 2026
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Latest earnings call · Aug 6, 2026
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 49 slides
Calls
Replays
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Sep 8, 2026
Closed $1.09 (+0.9%) on Sep 8, 2026
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $1.10 (-2.7%) on Aug 7, 2026
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Jul 30, 2026
Closed $1.11 (+4.7%) on Jul 30, 2026
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
Jul 13, 2026
Closed $1.21 (-5.5%) on Jul 13, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 49 slides · Sep 14, 2026
Retinal Innovation Summit 2026
Conference · 22 slides · 2026
Q1 2025 Earnings Presentation
Earnings · 38 slides · May 13, 2025
Q4 2024 Earnings Presentation
Earnings · 43 slides · Mar 10, 2025
Lineage Cell Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 30 in all · newest Sep 8, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Aug 6, 2026
- Decks
- 21 decks · latest Sep 14, 2026
Where Lineage Cell Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:LCTX · Home listing | NYSE American | United States | USD |
| TASE:LCTX | TASE | Israel | ILA |
| gettex:BT3 | gettex | Germany | EUR |
| LS Exchange:A2PP89 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PP89 | Lang & Schwarz | Germany | EUR |
| BOATS:LCTX | BOATS | United States | USD |
| Frankfurt:BT3 | Frankfurt | Germany | EUR |
| Tradegate:BT3 · This page | Tradegate | Germany | EUR |
| Dusseldorf:BT3 | Dusseldorf | Germany | EUR |
| Stuttgart:BT3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Lineage Cell Therapeutics, Inc.